✦ LIBER ✦

A Review of CT-P13: An Infliximab Biosimilar

✍ Scribed by McKeage, Kate

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Introduction of an Infliximab Biosimilar

✍ McCarthy, G.; Ebel Bitoun, C.; Guy, H. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Budget impact analysis of biosimilar inf

✍ Brodszky, Valentin; Baji, Petra; Balogh, Orsolya; Péntek, Márta 📂 Article 📅 2014 🏛 Springer 🌐 French ⚖ 287 KB

P565 An experience of anti-TNF biosimila

✍ Kang, H.W.; Lim, Y.J.; Kim, J.H.; Kang, Y.-S. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 52 KB

Comparative efficacy and safety of biosi

✍ Baji, Petra; Péntek, Márta; Szántó, Sándor; Géher, Pál; Gulácsi, László; Balogh, 📂 Article 📅 2014 🏛 Springer 🌐 French ⚖ 530 KB

Efficacy and safety of infliximab-biosim

✍ Baji, Petra; Péntek, Márta; Czirják, László; Szekanecz, Zoltán; Nagy, György; Gu 📂 Article 📅 2014 🏛 Springer 🌐 French ⚖ 850 KB

Tues-P13 - Health economics of antidepre

✍ T.R. Hylan; D.P. Buesching; G.D. Tollefson 📂 Article 📅 1998 🏛 Elsevier Science 🌐 French ⚖ 128 KB